Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker RDWR
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Gabriel Malka Chief Operating Officer | RDWR Radware Ltd. | Sale | 16,461 | $34.23 | $563.5K Sale | Form 4 ↗ |
| Oct 30, 2026 | Yair Tauman Director | RDWR Radware Ltd. | Sale | 1,919 | $36.05 | $69.2K Sale | Form 4 ↗ |
| Oct 28, 2026 | Rivkah Goldriech Chief People Officer | RDWR Radware Ltd. | Sale | 4,125 | $36.00 | $148.5K Sale | Form 4 ↗ |
| Oct 28, 2026 | David Meleh Aviv Chief Technology Officer | RDWR Radware Ltd. | Sale | 7,500 | $36.28 | $272.1K Sale | Form 4 ↗ |
| Oct 27, 2026 | Rivkah Goldriech Chief People Officer | RDWR Radware Ltd. | Sale | 100 | $35.01 | $3,501 Sale | Form 4 ↗ |
| Oct 27, 2026 | Rivkah Goldriech Chief People Officer | RDWR Radware Ltd. | Sale | 24,177 | $34.66 | $838.0K Sale | Form 4 ↗ |
| Oct 27, 2026 | David Meleh Aviv Chief Technology Officer | RDWR Radware Ltd. | Sale | 10,000 | $35.13 | $351.3K Sale | Form 4 ↗ |
| Oct 27, 2026 | David Meleh Aviv Chief Technology Officer | RDWR Radware Ltd. | Sale | 7,500 | $34.12 | $255.9K Sale | Form 4 ↗ |
| Oct 26, 2026 | David Meleh Aviv Chief Technology Officer | RDWR Radware Ltd. | Sale | 12,500 | $32.05 | $400.6K Sale | Form 4 ↗ |
| Sep 17, 2026 | David Meleh Aviv Chief Technology Officer | RDWR Radware Ltd. | Sale | 15,000 | $30.71 | $460.6K Sale | Form 4 ↗ |
| Aug 27, 2026 | Gabriel Malka Chief Operating Officer | RDWR Radware Ltd. | Sale | 6,500 | $30.00 | $195.0K Sale | Form 4 ↗ |
| Jul 31, 2026 | Guy Avidan Chief Financial Officer | RDWR Radware Ltd. | Buy | 2,000 | $25.21 | $50.4K Buy | Form 4 ↗ |
| Jul 9, 2026 | Rivkah Goldriech Chief People Officer | RDWR Radware Ltd. | Sale | 750 | $32.00 | $24.0K Sale | Form 4 ↗ |
| May 29, 2026 | Gabriel Malka Chief Operating Officer | RDWR Radware Ltd. | Sale | 7,000 | $30.00 | $210.0K Sale | Form 4 ↗ |
| May 22, 2026 | Rivkah Goldriech Chief People Officer | RDWR Radware Ltd. | Sale | 1,375 | $29.50 | $40.6K Sale | Form 4 ↗ |
| May 8, 2026 | Gabriel Malka Chief Operating Officer | RDWR Radware Ltd. | Sale | 3,111 | $29.00 | $90.2K Sale | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances